In clinical practice, the assessment of liver disease severity and functional impairment predominantly relies on clinical signs and blood biochemical markers, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum albumin (ALB), total bilirubin (TB), prothrombin time (PT), along with manifestations like ascites and hepatic encephalopathy [9, 10]. Here, ALB is linked to liver disorder.